nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ORM1—Tacrolimus—atopic dermatitis	0.0714	0.112	CbGbCtD
Imatinib—SLC22A2—Diphenhydramine—atopic dermatitis	0.0432	0.0679	CbGbCtD
Imatinib—SLC22A1—Diphenhydramine—atopic dermatitis	0.0376	0.059	CbGbCtD
Imatinib—CYP3A7—Tacrolimus—atopic dermatitis	0.0322	0.0506	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0322	0.0506	CbGbCtD
Imatinib—ALB—Tacrolimus—atopic dermatitis	0.0301	0.0472	CbGbCtD
Imatinib—PTGS1—Diphenhydramine—atopic dermatitis	0.0295	0.0462	CbGbCtD
Imatinib—CYP3A5—Tacrolimus—atopic dermatitis	0.0242	0.0379	CbGbCtD
Imatinib—ABCG2—Hydrocortisone—atopic dermatitis	0.0178	0.0279	CbGbCtD
Imatinib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0158	0.0249	CbGbCtD
Imatinib—ABCB1—Tacrolimus—atopic dermatitis	0.0157	0.0247	CbGbCtD
Imatinib—CYP2C19—Loratadine—atopic dermatitis	0.0143	0.0224	CbGbCtD
Imatinib—CYP2C19—Diphenhydramine—atopic dermatitis	0.0143	0.0224	CbGbCtD
Imatinib—CYP1A2—Diphenhydramine—atopic dermatitis	0.0132	0.0207	CbGbCtD
Imatinib—CYP3A7—Hydrocortisone—atopic dermatitis	0.0131	0.0206	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0131	0.0206	CbGbCtD
Imatinib—ALB—Prednisone—atopic dermatitis	0.0122	0.0191	CbGbCtD
Imatinib—CYP2C9—Diphenhydramine—atopic dermatitis	0.0119	0.0186	CbGbCtD
Imatinib—CYP2C9—Loratadine—atopic dermatitis	0.0119	0.0186	CbGbCtD
Imatinib—ABCB1—Loratadine—atopic dermatitis	0.0115	0.0181	CbGbCtD
Imatinib—ABCG2—Dexamethasone—atopic dermatitis	0.011	0.0173	CbGbCtD
Imatinib—CYP2D6—Loratadine—atopic dermatitis	0.0108	0.017	CbGbCtD
Imatinib—CYP2D6—Diphenhydramine—atopic dermatitis	0.0108	0.017	CbGbCtD
Imatinib—ABCB1—Methylprednisolone—atopic dermatitis	0.0105	0.0165	CbGbCtD
Imatinib—CYP3A5—Hydrocortisone—atopic dermatitis	0.00984	0.0154	CbGbCtD
Imatinib—CYP3A4—Tacrolimus—atopic dermatitis	0.00942	0.0148	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00815	0.0128	CbGbCtD
Imatinib—CYP3A7—Dexamethasone—atopic dermatitis	0.00815	0.0128	CbGbCtD
Imatinib—CYP2C19—Prednisone—atopic dermatitis	0.0079	0.0124	CbGbCtD
Imatinib—CYP3A4—Loratadine—atopic dermatitis	0.0069	0.0108	CbGbCtD
Imatinib—ABCB1—Betamethasone—atopic dermatitis	0.00684	0.0107	CbGbCtD
Imatinib—ABCB1—Prednisolone—atopic dermatitis	0.00675	0.0106	CbGbCtD
Imatinib—ABCB1—Hydrocortisone—atopic dermatitis	0.0064	0.01	CbGbCtD
Imatinib—ABCB1—Prednisone—atopic dermatitis	0.00638	0.01	CbGbCtD
Imatinib—CYP3A4—Methylprednisolone—atopic dermatitis	0.00631	0.0099	CbGbCtD
Imatinib—CYP3A5—Dexamethasone—atopic dermatitis	0.00612	0.0096	CbGbCtD
Imatinib—CA6—ear—atopic dermatitis	0.00592	0.188	CbGeAlD
Imatinib—CA3—ear—atopic dermatitis	0.00561	0.178	CbGeAlD
Imatinib—CYP2C19—Dexamethasone—atopic dermatitis	0.00493	0.00775	CbGbCtD
Imatinib—CYP3A4—Triamcinolone—atopic dermatitis	0.00478	0.0075	CbGbCtD
Imatinib—Nilotinib—MAPK8—atopic dermatitis	0.00461	1	CrCbGaD
Imatinib—CYP2C9—Dexamethasone—atopic dermatitis	0.0041	0.00644	CbGbCtD
Imatinib—CYP3A4—Betamethasone—atopic dermatitis	0.0041	0.00644	CbGbCtD
Imatinib—CYP3A4—Prednisolone—atopic dermatitis	0.00405	0.00635	CbGbCtD
Imatinib—ABCB1—Dexamethasone—atopic dermatitis	0.00398	0.00625	CbGbCtD
Imatinib—CYP3A4—Hydrocortisone—atopic dermatitis	0.00384	0.00602	CbGbCtD
Imatinib—CYP3A4—Prednisone—atopic dermatitis	0.00382	0.006	CbGbCtD
Imatinib—CYP2D6—Dexamethasone—atopic dermatitis	0.00375	0.00589	CbGbCtD
Imatinib—KIT—skin epidermis—atopic dermatitis	0.00254	0.0808	CbGeAlD
Imatinib—CYP3A4—Dexamethasone—atopic dermatitis	0.00239	0.00374	CbGbCtD
Imatinib—ABCA3—head—atopic dermatitis	0.00154	0.0489	CbGeAlD
Imatinib—KIT—neck—atopic dermatitis	0.00122	0.0387	CbGeAlD
Imatinib—PDGFRB—neck—atopic dermatitis	0.00119	0.0378	CbGeAlD
Imatinib—CA6—head—atopic dermatitis	0.000884	0.0281	CbGeAlD
Imatinib—PIP4K2C—head—atopic dermatitis	0.000877	0.0279	CbGeAlD
Imatinib—CSF1R—skin of body—atopic dermatitis	0.000867	0.0276	CbGeAlD
Imatinib—CA3—head—atopic dermatitis	0.000838	0.0266	CbGeAlD
Imatinib—KIT—skin of body—atopic dermatitis	0.000787	0.025	CbGeAlD
Imatinib—PDGFRB—skin of body—atopic dermatitis	0.000769	0.0244	CbGeAlD
Imatinib—CA2—neck—atopic dermatitis	0.000721	0.0229	CbGeAlD
Imatinib—ABL1—skin of body—atopic dermatitis	0.000685	0.0218	CbGeAlD
Imatinib—NQO2—head—atopic dermatitis	0.000644	0.0205	CbGeAlD
Imatinib—PDGFRA—head—atopic dermatitis	0.000643	0.0204	CbGeAlD
Imatinib—CA12—head—atopic dermatitis	0.000593	0.0188	CbGeAlD
Imatinib—CSF1R—head—atopic dermatitis	0.000566	0.018	CbGeAlD
Imatinib—SLC47A1—head—atopic dermatitis	0.000517	0.0164	CbGeAlD
Imatinib—KIT—head—atopic dermatitis	0.000514	0.0163	CbGeAlD
Imatinib—PDGFRB—head—atopic dermatitis	0.000502	0.0159	CbGeAlD
Imatinib—CA1—head—atopic dermatitis	0.00047	0.0149	CbGeAlD
Imatinib—CA2—skin of body—atopic dermatitis	0.000467	0.0148	CbGeAlD
Imatinib—ABL1—head—atopic dermatitis	0.000447	0.0142	CbGeAlD
Imatinib—SLC22A1—head—atopic dermatitis	0.000431	0.0137	CbGeAlD
Imatinib—PTGS1—skin of body—atopic dermatitis	0.000361	0.0115	CbGeAlD
Imatinib—CA2—head—atopic dermatitis	0.000305	0.00968	CbGeAlD
Imatinib—PTGS1—head—atopic dermatitis	0.000235	0.00747	CbGeAlD
Imatinib—CYP2D6—head—atopic dermatitis	0.000193	0.00614	CbGeAlD
Imatinib—ABCB1—head—atopic dermatitis	0.000139	0.00442	CbGeAlD
Imatinib—Tachycardia—Prednisolone—atopic dermatitis	6.73e-05	0.000272	CcSEcCtD
Imatinib—Convulsion—Methylprednisolone—atopic dermatitis	6.72e-05	0.000271	CcSEcCtD
Imatinib—Hypertension—Triamcinolone—atopic dermatitis	6.71e-05	0.000271	CcSEcCtD
Imatinib—Hypertension—Methylprednisolone—atopic dermatitis	6.69e-05	0.00027	CcSEcCtD
Imatinib—Infection—Hydrocortisone—atopic dermatitis	6.69e-05	0.00027	CcSEcCtD
Imatinib—Hyperhidrosis—Prednisolone—atopic dermatitis	6.66e-05	0.000269	CcSEcCtD
Imatinib—Shock—Hydrocortisone—atopic dermatitis	6.62e-05	0.000267	CcSEcCtD
Imatinib—Myalgia—Triamcinolone—atopic dermatitis	6.61e-05	0.000267	CcSEcCtD
Imatinib—Nervous system disorder—Hydrocortisone—atopic dermatitis	6.6e-05	0.000267	CcSEcCtD
Imatinib—Arthralgia—Methylprednisolone—atopic dermatitis	6.6e-05	0.000266	CcSEcCtD
Imatinib—Myalgia—Methylprednisolone—atopic dermatitis	6.6e-05	0.000266	CcSEcCtD
Imatinib—Eye disorder—Prednisone—atopic dermatitis	6.59e-05	0.000266	CcSEcCtD
Imatinib—Anxiety—Methylprednisolone—atopic dermatitis	6.58e-05	0.000265	CcSEcCtD
Imatinib—Tachycardia—Hydrocortisone—atopic dermatitis	6.57e-05	0.000265	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	6.55e-05	0.000265	CcSEcCtD
Imatinib—Flushing—Prednisone—atopic dermatitis	6.54e-05	0.000264	CcSEcCtD
Imatinib—Skin disorder—Hydrocortisone—atopic dermatitis	6.54e-05	0.000264	CcSEcCtD
Imatinib—Ill-defined disorder—Dexamethasone—atopic dermatitis	6.54e-05	0.000264	CcSEcCtD
Imatinib—Ill-defined disorder—Betamethasone—atopic dermatitis	6.54e-05	0.000264	CcSEcCtD
Imatinib—Discomfort—Triamcinolone—atopic dermatitis	6.53e-05	0.000264	CcSEcCtD
Imatinib—Discomfort—Methylprednisolone—atopic dermatitis	6.52e-05	0.000263	CcSEcCtD
Imatinib—Hyperhidrosis—Hydrocortisone—atopic dermatitis	6.51e-05	0.000263	CcSEcCtD
Imatinib—Dry mouth—Triamcinolone—atopic dermatitis	6.47e-05	0.000261	CcSEcCtD
Imatinib—Angioedema—Dexamethasone—atopic dermatitis	6.44e-05	0.00026	CcSEcCtD
Imatinib—Angioedema—Betamethasone—atopic dermatitis	6.44e-05	0.00026	CcSEcCtD
Imatinib—Anorexia—Hydrocortisone—atopic dermatitis	6.42e-05	0.000259	CcSEcCtD
Imatinib—Nausea—Tacrolimus—atopic dermatitis	6.41e-05	0.000259	CcSEcCtD
Imatinib—Angiopathy—Prednisone—atopic dermatitis	6.4e-05	0.000258	CcSEcCtD
Imatinib—Confusional state—Methylprednisolone—atopic dermatitis	6.38e-05	0.000257	CcSEcCtD
Imatinib—Immune system disorder—Prednisone—atopic dermatitis	6.37e-05	0.000257	CcSEcCtD
Imatinib—Malaise—Betamethasone—atopic dermatitis	6.36e-05	0.000257	CcSEcCtD
Imatinib—Malaise—Dexamethasone—atopic dermatitis	6.36e-05	0.000257	CcSEcCtD
Imatinib—Anaphylactic shock—Triamcinolone—atopic dermatitis	6.34e-05	0.000256	CcSEcCtD
Imatinib—Oedema—Triamcinolone—atopic dermatitis	6.34e-05	0.000256	CcSEcCtD
Imatinib—Vertigo—Dexamethasone—atopic dermatitis	6.33e-05	0.000256	CcSEcCtD
Imatinib—Vertigo—Betamethasone—atopic dermatitis	6.33e-05	0.000256	CcSEcCtD
Imatinib—Anaphylactic shock—Methylprednisolone—atopic dermatitis	6.33e-05	0.000255	CcSEcCtD
Imatinib—Syncope—Betamethasone—atopic dermatitis	6.32e-05	0.000255	CcSEcCtD
Imatinib—Syncope—Dexamethasone—atopic dermatitis	6.32e-05	0.000255	CcSEcCtD
Imatinib—Arrhythmia—Prednisone—atopic dermatitis	6.3e-05	0.000254	CcSEcCtD
Imatinib—Infection—Triamcinolone—atopic dermatitis	6.3e-05	0.000254	CcSEcCtD
Imatinib—Hypotension—Hydrocortisone—atopic dermatitis	6.29e-05	0.000254	CcSEcCtD
Imatinib—Infection—Methylprednisolone—atopic dermatitis	6.28e-05	0.000254	CcSEcCtD
Imatinib—Shock—Triamcinolone—atopic dermatitis	6.24e-05	0.000252	CcSEcCtD
Imatinib—Insomnia—Prednisolone—atopic dermatitis	6.24e-05	0.000252	CcSEcCtD
Imatinib—Alopecia—Prednisone—atopic dermatitis	6.23e-05	0.000252	CcSEcCtD
Imatinib—Shock—Methylprednisolone—atopic dermatitis	6.22e-05	0.000251	CcSEcCtD
Imatinib—Nervous system disorder—Methylprednisolone—atopic dermatitis	6.2e-05	0.00025	CcSEcCtD
Imatinib—Loss of consciousness—Betamethasone—atopic dermatitis	6.2e-05	0.00025	CcSEcCtD
Imatinib—Loss of consciousness—Dexamethasone—atopic dermatitis	6.2e-05	0.00025	CcSEcCtD
Imatinib—Paraesthesia—Prednisolone—atopic dermatitis	6.19e-05	0.00025	CcSEcCtD
Imatinib—Tachycardia—Triamcinolone—atopic dermatitis	6.19e-05	0.00025	CcSEcCtD
Imatinib—Mental disorder—Prednisone—atopic dermatitis	6.18e-05	0.000249	CcSEcCtD
Imatinib—Tachycardia—Methylprednisolone—atopic dermatitis	6.17e-05	0.000249	CcSEcCtD
Imatinib—Skin disorder—Methylprednisolone—atopic dermatitis	6.14e-05	0.000248	CcSEcCtD
Imatinib—Erythema—Prednisone—atopic dermatitis	6.14e-05	0.000248	CcSEcCtD
Imatinib—Malnutrition—Prednisone—atopic dermatitis	6.14e-05	0.000248	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	6.13e-05	0.000248	CcSEcCtD
Imatinib—Hyperhidrosis—Triamcinolone—atopic dermatitis	6.13e-05	0.000247	CcSEcCtD
Imatinib—Hyperhidrosis—Methylprednisolone—atopic dermatitis	6.12e-05	0.000247	CcSEcCtD
Imatinib—Convulsion—Betamethasone—atopic dermatitis	6.11e-05	0.000247	CcSEcCtD
Imatinib—Convulsion—Dexamethasone—atopic dermatitis	6.11e-05	0.000247	CcSEcCtD
Imatinib—Insomnia—Hydrocortisone—atopic dermatitis	6.09e-05	0.000246	CcSEcCtD
Imatinib—Hypertension—Dexamethasone—atopic dermatitis	6.09e-05	0.000246	CcSEcCtD
Imatinib—Hypertension—Betamethasone—atopic dermatitis	6.09e-05	0.000246	CcSEcCtD
Imatinib—Paraesthesia—Hydrocortisone—atopic dermatitis	6.05e-05	0.000244	CcSEcCtD
Imatinib—Myalgia—Betamethasone—atopic dermatitis	6e-05	0.000242	CcSEcCtD
Imatinib—Myalgia—Dexamethasone—atopic dermatitis	6e-05	0.000242	CcSEcCtD
Imatinib—Anxiety—Dexamethasone—atopic dermatitis	5.98e-05	0.000241	CcSEcCtD
Imatinib—Anxiety—Betamethasone—atopic dermatitis	5.98e-05	0.000241	CcSEcCtD
Imatinib—Discomfort—Dexamethasone—atopic dermatitis	5.93e-05	0.000239	CcSEcCtD
Imatinib—Discomfort—Betamethasone—atopic dermatitis	5.93e-05	0.000239	CcSEcCtD
Imatinib—Dyspepsia—Hydrocortisone—atopic dermatitis	5.93e-05	0.000239	CcSEcCtD
Imatinib—Hypotension—Methylprednisolone—atopic dermatitis	5.91e-05	0.000239	CcSEcCtD
Imatinib—Pain—Prednisolone—atopic dermatitis	5.9e-05	0.000238	CcSEcCtD
Imatinib—Decreased appetite—Hydrocortisone—atopic dermatitis	5.85e-05	0.000236	CcSEcCtD
Imatinib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	5.81e-05	0.000235	CcSEcCtD
Imatinib—Fatigue—Hydrocortisone—atopic dermatitis	5.8e-05	0.000234	CcSEcCtD
Imatinib—Vision blurred—Prednisone—atopic dermatitis	5.78e-05	0.000234	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	5.78e-05	0.000233	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	5.76e-05	0.000233	CcSEcCtD
Imatinib—Pain—Hydrocortisone—atopic dermatitis	5.76e-05	0.000232	CcSEcCtD
Imatinib—Anaphylactic shock—Dexamethasone—atopic dermatitis	5.75e-05	0.000232	CcSEcCtD
Imatinib—Oedema—Dexamethasone—atopic dermatitis	5.75e-05	0.000232	CcSEcCtD
Imatinib—Oedema—Betamethasone—atopic dermatitis	5.75e-05	0.000232	CcSEcCtD
Imatinib—Anaphylactic shock—Betamethasone—atopic dermatitis	5.75e-05	0.000232	CcSEcCtD
Imatinib—Insomnia—Triamcinolone—atopic dermatitis	5.73e-05	0.000231	CcSEcCtD
Imatinib—Insomnia—Methylprednisolone—atopic dermatitis	5.72e-05	0.000231	CcSEcCtD
Imatinib—Infection—Betamethasone—atopic dermatitis	5.71e-05	0.000231	CcSEcCtD
Imatinib—Infection—Dexamethasone—atopic dermatitis	5.71e-05	0.000231	CcSEcCtD
Imatinib—Ill-defined disorder—Prednisone—atopic dermatitis	5.7e-05	0.00023	CcSEcCtD
Imatinib—Paraesthesia—Triamcinolone—atopic dermatitis	5.69e-05	0.00023	CcSEcCtD
Imatinib—Feeling abnormal—Prednisolone—atopic dermatitis	5.68e-05	0.000229	CcSEcCtD
Imatinib—Paraesthesia—Methylprednisolone—atopic dermatitis	5.68e-05	0.000229	CcSEcCtD
Imatinib—Anaemia—Prednisone—atopic dermatitis	5.67e-05	0.000229	CcSEcCtD
Imatinib—Shock—Betamethasone—atopic dermatitis	5.66e-05	0.000228	CcSEcCtD
Imatinib—Shock—Dexamethasone—atopic dermatitis	5.66e-05	0.000228	CcSEcCtD
Imatinib—Dyspnoea—Triamcinolone—atopic dermatitis	5.65e-05	0.000228	CcSEcCtD
Imatinib—Nervous system disorder—Dexamethasone—atopic dermatitis	5.64e-05	0.000228	CcSEcCtD
Imatinib—Nervous system disorder—Betamethasone—atopic dermatitis	5.64e-05	0.000228	CcSEcCtD
Imatinib—Thrombocytopenia—Betamethasone—atopic dermatitis	5.63e-05	0.000227	CcSEcCtD
Imatinib—Thrombocytopenia—Dexamethasone—atopic dermatitis	5.63e-05	0.000227	CcSEcCtD
Imatinib—Tachycardia—Dexamethasone—atopic dermatitis	5.61e-05	0.000227	CcSEcCtD
Imatinib—Tachycardia—Betamethasone—atopic dermatitis	5.61e-05	0.000227	CcSEcCtD
Imatinib—Angioedema—Prednisone—atopic dermatitis	5.61e-05	0.000226	CcSEcCtD
Imatinib—Dyspepsia—Triamcinolone—atopic dermatitis	5.58e-05	0.000225	CcSEcCtD
Imatinib—Dyspepsia—Methylprednisolone—atopic dermatitis	5.57e-05	0.000225	CcSEcCtD
Imatinib—Hyperhidrosis—Betamethasone—atopic dermatitis	5.56e-05	0.000224	CcSEcCtD
Imatinib—Hyperhidrosis—Dexamethasone—atopic dermatitis	5.56e-05	0.000224	CcSEcCtD
Imatinib—Feeling abnormal—Hydrocortisone—atopic dermatitis	5.55e-05	0.000224	CcSEcCtD
Imatinib—Malaise—Prednisone—atopic dermatitis	5.54e-05	0.000223	CcSEcCtD
Imatinib—Vertigo—Prednisone—atopic dermatitis	5.51e-05	0.000223	CcSEcCtD
Imatinib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	5.51e-05	0.000222	CcSEcCtD
Imatinib—Syncope—Prednisone—atopic dermatitis	5.5e-05	0.000222	CcSEcCtD
Imatinib—Anorexia—Dexamethasone—atopic dermatitis	5.48e-05	0.000221	CcSEcCtD
Imatinib—Anorexia—Betamethasone—atopic dermatitis	5.48e-05	0.000221	CcSEcCtD
Imatinib—Urticaria—Prednisolone—atopic dermatitis	5.48e-05	0.000221	CcSEcCtD
Imatinib—Fatigue—Triamcinolone—atopic dermatitis	5.47e-05	0.000221	CcSEcCtD
Imatinib—Fatigue—Methylprednisolone—atopic dermatitis	5.45e-05	0.00022	CcSEcCtD
Imatinib—Pain—Triamcinolone—atopic dermatitis	5.42e-05	0.000219	CcSEcCtD
Imatinib—Loss of consciousness—Prednisone—atopic dermatitis	5.4e-05	0.000218	CcSEcCtD
Imatinib—Hypotension—Dexamethasone—atopic dermatitis	5.38e-05	0.000217	CcSEcCtD
Imatinib—Hypotension—Betamethasone—atopic dermatitis	5.38e-05	0.000217	CcSEcCtD
Imatinib—Urticaria—Hydrocortisone—atopic dermatitis	5.35e-05	0.000216	CcSEcCtD
Imatinib—Abdominal pain—Hydrocortisone—atopic dermatitis	5.32e-05	0.000215	CcSEcCtD
Imatinib—Body temperature increased—Hydrocortisone—atopic dermatitis	5.32e-05	0.000215	CcSEcCtD
Imatinib—Convulsion—Prednisone—atopic dermatitis	5.32e-05	0.000215	CcSEcCtD
Imatinib—Hypertension—Prednisone—atopic dermatitis	5.3e-05	0.000214	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	5.24e-05	0.000212	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	5.24e-05	0.000212	CcSEcCtD
Imatinib—Myalgia—Prednisone—atopic dermatitis	5.23e-05	0.000211	CcSEcCtD
Imatinib—Arthralgia—Prednisone—atopic dermatitis	5.23e-05	0.000211	CcSEcCtD
Imatinib—Feeling abnormal—Triamcinolone—atopic dermatitis	5.22e-05	0.000211	CcSEcCtD
Imatinib—Feeling abnormal—Methylprednisolone—atopic dermatitis	5.21e-05	0.00021	CcSEcCtD
Imatinib—Anxiety—Prednisone—atopic dermatitis	5.21e-05	0.00021	CcSEcCtD
Imatinib—Insomnia—Dexamethasone—atopic dermatitis	5.2e-05	0.00021	CcSEcCtD
Imatinib—Insomnia—Betamethasone—atopic dermatitis	5.2e-05	0.00021	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	5.19e-05	0.000209	CcSEcCtD
Imatinib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	5.17e-05	0.000209	CcSEcCtD
Imatinib—Paraesthesia—Betamethasone—atopic dermatitis	5.17e-05	0.000209	CcSEcCtD
Imatinib—Paraesthesia—Dexamethasone—atopic dermatitis	5.17e-05	0.000209	CcSEcCtD
Imatinib—Discomfort—Prednisone—atopic dermatitis	5.16e-05	0.000208	CcSEcCtD
Imatinib—Hypersensitivity—Prednisolone—atopic dermatitis	5.08e-05	0.000205	CcSEcCtD
Imatinib—Dyspepsia—Betamethasone—atopic dermatitis	5.06e-05	0.000204	CcSEcCtD
Imatinib—Dyspepsia—Dexamethasone—atopic dermatitis	5.06e-05	0.000204	CcSEcCtD
Imatinib—Urticaria—Triamcinolone—atopic dermatitis	5.04e-05	0.000203	CcSEcCtD
Imatinib—Urticaria—Methylprednisolone—atopic dermatitis	5.03e-05	0.000203	CcSEcCtD
Imatinib—Body temperature increased—Triamcinolone—atopic dermatitis	5.01e-05	0.000202	CcSEcCtD
Imatinib—Anaphylactic shock—Prednisone—atopic dermatitis	5.01e-05	0.000202	CcSEcCtD
Imatinib—Oedema—Prednisone—atopic dermatitis	5.01e-05	0.000202	CcSEcCtD
Imatinib—Abdominal pain—Methylprednisolone—atopic dermatitis	5e-05	0.000202	CcSEcCtD
Imatinib—Decreased appetite—Dexamethasone—atopic dermatitis	5e-05	0.000202	CcSEcCtD
Imatinib—Decreased appetite—Betamethasone—atopic dermatitis	5e-05	0.000202	CcSEcCtD
Imatinib—Infection—Prednisone—atopic dermatitis	4.98e-05	0.000201	CcSEcCtD
Imatinib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	4.97e-05	0.0002	CcSEcCtD
Imatinib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	4.97e-05	0.0002	CcSEcCtD
Imatinib—Hypersensitivity—Hydrocortisone—atopic dermatitis	4.96e-05	0.0002	CcSEcCtD
Imatinib—Fatigue—Betamethasone—atopic dermatitis	4.96e-05	0.0002	CcSEcCtD
Imatinib—Fatigue—Dexamethasone—atopic dermatitis	4.96e-05	0.0002	CcSEcCtD
Imatinib—Shock—Prednisone—atopic dermatitis	4.93e-05	0.000199	CcSEcCtD
Imatinib—Pain—Betamethasone—atopic dermatitis	4.92e-05	0.000199	CcSEcCtD
Imatinib—Pain—Dexamethasone—atopic dermatitis	4.92e-05	0.000199	CcSEcCtD
Imatinib—Nervous system disorder—Prednisone—atopic dermatitis	4.91e-05	0.000198	CcSEcCtD
Imatinib—Tachycardia—Prednisone—atopic dermatitis	4.89e-05	0.000197	CcSEcCtD
Imatinib—Skin disorder—Prednisone—atopic dermatitis	4.87e-05	0.000196	CcSEcCtD
Imatinib—Hyperhidrosis—Prednisone—atopic dermatitis	4.84e-05	0.000195	CcSEcCtD
Imatinib—Asthenia—Hydrocortisone—atopic dermatitis	4.83e-05	0.000195	CcSEcCtD
Imatinib—Anorexia—Prednisone—atopic dermatitis	4.78e-05	0.000193	CcSEcCtD
Imatinib—Pruritus—Hydrocortisone—atopic dermatitis	4.76e-05	0.000192	CcSEcCtD
Imatinib—Feeling abnormal—Dexamethasone—atopic dermatitis	4.74e-05	0.000191	CcSEcCtD
Imatinib—Feeling abnormal—Betamethasone—atopic dermatitis	4.74e-05	0.000191	CcSEcCtD
Imatinib—Gastrointestinal pain—Betamethasone—atopic dermatitis	4.7e-05	0.00019	CcSEcCtD
Imatinib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	4.7e-05	0.00019	CcSEcCtD
Imatinib—Hypersensitivity—Triamcinolone—atopic dermatitis	4.67e-05	0.000189	CcSEcCtD
Imatinib—Hypersensitivity—Methylprednisolone—atopic dermatitis	4.66e-05	0.000188	CcSEcCtD
Imatinib—Diarrhoea—Hydrocortisone—atopic dermatitis	4.61e-05	0.000186	CcSEcCtD
Imatinib—Urticaria—Betamethasone—atopic dermatitis	4.57e-05	0.000184	CcSEcCtD
Imatinib—Urticaria—Dexamethasone—atopic dermatitis	4.57e-05	0.000184	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	4.56e-05	0.000184	CcSEcCtD
Imatinib—Dizziness—Prednisolone—atopic dermatitis	4.56e-05	0.000184	CcSEcCtD
Imatinib—Asthenia—Triamcinolone—atopic dermatitis	4.55e-05	0.000184	CcSEcCtD
Imatinib—Abdominal pain—Betamethasone—atopic dermatitis	4.55e-05	0.000184	CcSEcCtD
Imatinib—Body temperature increased—Dexamethasone—atopic dermatitis	4.55e-05	0.000184	CcSEcCtD
Imatinib—Abdominal pain—Dexamethasone—atopic dermatitis	4.55e-05	0.000184	CcSEcCtD
Imatinib—Body temperature increased—Betamethasone—atopic dermatitis	4.55e-05	0.000184	CcSEcCtD
Imatinib—Asthenia—Methylprednisolone—atopic dermatitis	4.54e-05	0.000183	CcSEcCtD
Imatinib—Insomnia—Prednisone—atopic dermatitis	4.53e-05	0.000183	CcSEcCtD
Imatinib—Paraesthesia—Prednisone—atopic dermatitis	4.5e-05	0.000182	CcSEcCtD
Imatinib—Pruritus—Triamcinolone—atopic dermatitis	4.49e-05	0.000181	CcSEcCtD
Imatinib—Pruritus—Methylprednisolone—atopic dermatitis	4.48e-05	0.000181	CcSEcCtD
Imatinib—Dizziness—Hydrocortisone—atopic dermatitis	4.45e-05	0.00018	CcSEcCtD
Imatinib—Dyspepsia—Prednisone—atopic dermatitis	4.41e-05	0.000178	CcSEcCtD
Imatinib—Decreased appetite—Prednisone—atopic dermatitis	4.35e-05	0.000176	CcSEcCtD
Imatinib—Rash—Prednisolone—atopic dermatitis	4.35e-05	0.000175	CcSEcCtD
Imatinib—Dermatitis—Prednisolone—atopic dermatitis	4.34e-05	0.000175	CcSEcCtD
Imatinib—Diarrhoea—Methylprednisolone—atopic dermatitis	4.33e-05	0.000175	CcSEcCtD
Imatinib—Fatigue—Prednisone—atopic dermatitis	4.32e-05	0.000174	CcSEcCtD
Imatinib—Headache—Prednisolone—atopic dermatitis	4.32e-05	0.000174	CcSEcCtD
Imatinib—Constipation—Prednisone—atopic dermatitis	4.28e-05	0.000173	CcSEcCtD
Imatinib—Vomiting—Hydrocortisone—atopic dermatitis	4.28e-05	0.000173	CcSEcCtD
Imatinib—Rash—Hydrocortisone—atopic dermatitis	4.25e-05	0.000171	CcSEcCtD
Imatinib—Dermatitis—Hydrocortisone—atopic dermatitis	4.24e-05	0.000171	CcSEcCtD
Imatinib—Headache—Hydrocortisone—atopic dermatitis	4.22e-05	0.00017	CcSEcCtD
Imatinib—Dizziness—Triamcinolone—atopic dermatitis	4.19e-05	0.000169	CcSEcCtD
Imatinib—Dizziness—Methylprednisolone—atopic dermatitis	4.18e-05	0.000169	CcSEcCtD
Imatinib—Feeling abnormal—Prednisone—atopic dermatitis	4.13e-05	0.000167	CcSEcCtD
Imatinib—Asthenia—Betamethasone—atopic dermatitis	4.13e-05	0.000167	CcSEcCtD
Imatinib—Asthenia—Dexamethasone—atopic dermatitis	4.13e-05	0.000167	CcSEcCtD
Imatinib—Gastrointestinal pain—Prednisone—atopic dermatitis	4.1e-05	0.000165	CcSEcCtD
Imatinib—Nausea—Prednisolone—atopic dermatitis	4.09e-05	0.000165	CcSEcCtD
Imatinib—Pruritus—Dexamethasone—atopic dermatitis	4.07e-05	0.000164	CcSEcCtD
Imatinib—Pruritus—Betamethasone—atopic dermatitis	4.07e-05	0.000164	CcSEcCtD
Imatinib—Vomiting—Triamcinolone—atopic dermatitis	4.03e-05	0.000163	CcSEcCtD
Imatinib—Vomiting—Methylprednisolone—atopic dermatitis	4.02e-05	0.000162	CcSEcCtD
Imatinib—Nausea—Hydrocortisone—atopic dermatitis	4e-05	0.000161	CcSEcCtD
Imatinib—Rash—Triamcinolone—atopic dermatitis	4e-05	0.000161	CcSEcCtD
Imatinib—Dermatitis—Triamcinolone—atopic dermatitis	3.99e-05	0.000161	CcSEcCtD
Imatinib—Rash—Methylprednisolone—atopic dermatitis	3.99e-05	0.000161	CcSEcCtD
Imatinib—Dermatitis—Methylprednisolone—atopic dermatitis	3.98e-05	0.000161	CcSEcCtD
Imatinib—Urticaria—Prednisone—atopic dermatitis	3.98e-05	0.000161	CcSEcCtD
Imatinib—Headache—Triamcinolone—atopic dermatitis	3.97e-05	0.00016	CcSEcCtD
Imatinib—Headache—Methylprednisolone—atopic dermatitis	3.96e-05	0.00016	CcSEcCtD
Imatinib—Body temperature increased—Prednisone—atopic dermatitis	3.96e-05	0.00016	CcSEcCtD
Imatinib—Abdominal pain—Prednisone—atopic dermatitis	3.96e-05	0.00016	CcSEcCtD
Imatinib—Diarrhoea—Betamethasone—atopic dermatitis	3.94e-05	0.000159	CcSEcCtD
Imatinib—Diarrhoea—Dexamethasone—atopic dermatitis	3.94e-05	0.000159	CcSEcCtD
Imatinib—Dizziness—Dexamethasone—atopic dermatitis	3.8e-05	0.000154	CcSEcCtD
Imatinib—Dizziness—Betamethasone—atopic dermatitis	3.8e-05	0.000154	CcSEcCtD
Imatinib—Nausea—Triamcinolone—atopic dermatitis	3.77e-05	0.000152	CcSEcCtD
Imatinib—Nausea—Methylprednisolone—atopic dermatitis	3.76e-05	0.000152	CcSEcCtD
Imatinib—Hypersensitivity—Prednisone—atopic dermatitis	3.69e-05	0.000149	CcSEcCtD
Imatinib—Vomiting—Dexamethasone—atopic dermatitis	3.66e-05	0.000148	CcSEcCtD
Imatinib—Vomiting—Betamethasone—atopic dermatitis	3.66e-05	0.000148	CcSEcCtD
Imatinib—Rash—Betamethasone—atopic dermatitis	3.63e-05	0.000146	CcSEcCtD
Imatinib—Rash—Dexamethasone—atopic dermatitis	3.63e-05	0.000146	CcSEcCtD
Imatinib—Dermatitis—Betamethasone—atopic dermatitis	3.62e-05	0.000146	CcSEcCtD
Imatinib—Dermatitis—Dexamethasone—atopic dermatitis	3.62e-05	0.000146	CcSEcCtD
Imatinib—Headache—Dexamethasone—atopic dermatitis	3.6e-05	0.000145	CcSEcCtD
Imatinib—Headache—Betamethasone—atopic dermatitis	3.6e-05	0.000145	CcSEcCtD
Imatinib—Asthenia—Prednisone—atopic dermatitis	3.59e-05	0.000145	CcSEcCtD
Imatinib—Pruritus—Prednisone—atopic dermatitis	3.54e-05	0.000143	CcSEcCtD
Imatinib—Diarrhoea—Prednisone—atopic dermatitis	3.43e-05	0.000138	CcSEcCtD
Imatinib—Nausea—Dexamethasone—atopic dermatitis	3.42e-05	0.000138	CcSEcCtD
Imatinib—Nausea—Betamethasone—atopic dermatitis	3.42e-05	0.000138	CcSEcCtD
Imatinib—Dizziness—Prednisone—atopic dermatitis	3.31e-05	0.000134	CcSEcCtD
Imatinib—Vomiting—Prednisone—atopic dermatitis	3.19e-05	0.000129	CcSEcCtD
Imatinib—Rash—Prednisone—atopic dermatitis	3.16e-05	0.000128	CcSEcCtD
Imatinib—Dermatitis—Prednisone—atopic dermatitis	3.16e-05	0.000127	CcSEcCtD
Imatinib—Headache—Prednisone—atopic dermatitis	3.14e-05	0.000127	CcSEcCtD
Imatinib—Nausea—Prednisone—atopic dermatitis	2.98e-05	0.00012	CcSEcCtD
Imatinib—PDGFRA—Innate Immune System—CASP8—atopic dermatitis	2.31e-05	0.000293	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—NFKBIA—atopic dermatitis	2.31e-05	0.000292	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCL11—atopic dermatitis	2.3e-05	0.000291	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CMA1—atopic dermatitis	2.3e-05	0.000291	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD8A—atopic dermatitis	2.3e-05	0.00029	CbGpPWpGaD
Imatinib—LCK—Signaling by SCF-KIT—IL6—atopic dermatitis	2.29e-05	0.00029	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—TLR2—atopic dermatitis	2.29e-05	0.00029	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL17—atopic dermatitis	2.29e-05	0.000289	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	2.26e-05	0.000286	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—IL2—atopic dermatitis	2.25e-05	0.000285	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—NFKBIA—atopic dermatitis	2.25e-05	0.000285	CbGpPWpGaD
Imatinib—ABL1—Immune System—TLR2—atopic dermatitis	2.23e-05	0.000282	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—NFKBIA—atopic dermatitis	2.22e-05	0.000281	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCR3—atopic dermatitis	2.2e-05	0.000278	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IL5—atopic dermatitis	2.2e-05	0.000278	CbGpPWpGaD
Imatinib—LCK—Downstream signaling of activated FGFR—IL6—atopic dermatitis	2.2e-05	0.000277	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.18e-05	0.000276	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—STAT6—atopic dermatitis	2.16e-05	0.000273	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—IL6—atopic dermatitis	2.16e-05	0.000273	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD79A—atopic dermatitis	2.15e-05	0.000272	CbGpPWpGaD
Imatinib—CA2—Metabolism—PPARA—atopic dermatitis	2.15e-05	0.000272	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.12e-05	0.000268	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CXCL10—atopic dermatitis	2.12e-05	0.000268	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	2.11e-05	0.000267	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD79A—atopic dermatitis	2.1e-05	0.000265	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—CASP8—atopic dermatitis	2.09e-05	0.000264	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCR3—atopic dermatitis	2.08e-05	0.000263	CbGpPWpGaD
Imatinib—KIT—Immune System—IL18—atopic dermatitis	2.07e-05	0.000261	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—IL6—atopic dermatitis	2.06e-05	0.000261	CbGpPWpGaD
Imatinib—CA1—Metabolism—PPARA—atopic dermatitis	2.06e-05	0.00026	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—IL6—atopic dermatitis	2.05e-05	0.000259	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—IL6—atopic dermatitis	2.04e-05	0.000258	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—MAPK8—atopic dermatitis	2.04e-05	0.000258	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—KIF3A—atopic dermatitis	2.04e-05	0.000258	CbGpPWpGaD
Imatinib—KIT—Immune System—CD8A—atopic dermatitis	2.04e-05	0.000257	CbGpPWpGaD
Imatinib—LCK—Immune System—CASP1—atopic dermatitis	2.03e-05	0.000257	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—IL6—atopic dermatitis	2.03e-05	0.000257	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—CASP8—atopic dermatitis	2.03e-05	0.000257	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GLB1—atopic dermatitis	2.02e-05	0.000255	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—CD4—atopic dermatitis	2.01e-05	0.000254	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	2e-05	0.000253	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.97e-05	0.00025	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TAC1—atopic dermatitis	1.96e-05	0.000248	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NPS—atopic dermatitis	1.96e-05	0.000248	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL18—atopic dermatitis	1.96e-05	0.000247	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.95e-05	0.000247	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ADSL—atopic dermatitis	1.94e-05	0.000245	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.93e-05	0.000244	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CD4—atopic dermatitis	1.93e-05	0.000244	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD8A—atopic dermatitis	1.93e-05	0.000244	CbGpPWpGaD
Imatinib—LCK—Immune System—IL5—atopic dermatitis	1.93e-05	0.000244	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CXCR3—atopic dermatitis	1.92e-05	0.000243	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—IL6—atopic dermatitis	1.91e-05	0.000242	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—IL6—atopic dermatitis	1.91e-05	0.000242	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	1.91e-05	0.000242	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—IL6—atopic dermatitis	1.9e-05	0.000241	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—CD4—atopic dermatitis	1.9e-05	0.00024	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—IL6—atopic dermatitis	1.9e-05	0.00024	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—IL6—atopic dermatitis	1.88e-05	0.000237	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCR3—atopic dermatitis	1.87e-05	0.000237	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—IL6—atopic dermatitis	1.87e-05	0.000236	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—NFKBIA—atopic dermatitis	1.86e-05	0.000234	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TAC1—atopic dermatitis	1.85e-05	0.000234	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NPS—atopic dermatitis	1.85e-05	0.000234	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL11—atopic dermatitis	1.84e-05	0.000233	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CMA1—atopic dermatitis	1.84e-05	0.000233	CbGpPWpGaD
Imatinib—LCK—Immune System—TLR2—atopic dermatitis	1.84e-05	0.000232	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CD4—atopic dermatitis	1.83e-05	0.000231	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CCL5—atopic dermatitis	1.82e-05	0.000231	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL5—atopic dermatitis	1.82e-05	0.00023	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CXCR3—atopic dermatitis	1.82e-05	0.00023	CbGpPWpGaD
Imatinib—CA9—Metabolism—PPARA—atopic dermatitis	1.81e-05	0.000229	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.8e-05	0.000228	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—IL6—atopic dermatitis	1.8e-05	0.000228	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—NFKBIA—atopic dermatitis	1.78e-05	0.000225	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL18—atopic dermatitis	1.76e-05	0.000223	CbGpPWpGaD
Imatinib—ALB—Metabolism—GLB1—atopic dermatitis	1.74e-05	0.00022	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD8A—atopic dermatitis	1.74e-05	0.000219	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—STAT6—atopic dermatitis	1.73e-05	0.000219	CbGpPWpGaD
Imatinib—LCK—Immune System—CD79A—atopic dermatitis	1.73e-05	0.000218	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL5—atopic dermatitis	1.72e-05	0.000218	CbGpPWpGaD
Imatinib—KIT—Disease—CCR5—atopic dermatitis	1.72e-05	0.000217	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL18—atopic dermatitis	1.72e-05	0.000217	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—CD4—atopic dermatitis	1.71e-05	0.000216	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—IL2—atopic dermatitis	1.71e-05	0.000216	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—MAPK8—atopic dermatitis	1.7e-05	0.000215	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	1.69e-05	0.000214	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD8A—atopic dermatitis	1.69e-05	0.000214	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NGF—atopic dermatitis	1.69e-05	0.000213	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CASP8—atopic dermatitis	1.67e-05	0.000211	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NPS—atopic dermatitis	1.67e-05	0.000211	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TAC1—atopic dermatitis	1.67e-05	0.000211	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—CD4—atopic dermatitis	1.67e-05	0.000211	CbGpPWpGaD
Imatinib—ALB—Metabolism—ADSL—atopic dermatitis	1.67e-05	0.000211	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CD4—atopic dermatitis	1.64e-05	0.000208	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CCR5—atopic dermatitis	1.64e-05	0.000208	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CXCR3—atopic dermatitis	1.64e-05	0.000207	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	1.63e-05	0.000206	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CCR5—atopic dermatitis	1.63e-05	0.000206	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—IL6—atopic dermatitis	1.62e-05	0.000205	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—MAPK8—atopic dermatitis	1.61e-05	0.000203	CbGpPWpGaD
Imatinib—KIT—Immune System—NFKBIA—atopic dermatitis	1.58e-05	0.0002	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GLB1—atopic dermatitis	1.56e-05	0.000197	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL5—atopic dermatitis	1.55e-05	0.000196	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CXCL10—atopic dermatitis	1.55e-05	0.000196	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GLB1—atopic dermatitis	1.52e-05	0.000193	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCR3—atopic dermatitis	1.5e-05	0.00019	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ADSL—atopic dermatitis	1.5e-05	0.000189	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NFKBIA—atopic dermatitis	1.49e-05	0.000189	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.48e-05	0.000187	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CXCL10—atopic dermatitis	1.47e-05	0.000186	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CCR5—atopic dermatitis	1.47e-05	0.000185	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ADSL—atopic dermatitis	1.46e-05	0.000185	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—MAPK8—atopic dermatitis	1.45e-05	0.000183	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.44e-05	0.000182	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—IL6—atopic dermatitis	1.43e-05	0.000181	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GLB1—atopic dermatitis	1.42e-05	0.00018	CbGpPWpGaD
Imatinib—KIT—Immune System—CASP8—atopic dermatitis	1.42e-05	0.00018	CbGpPWpGaD
Imatinib—LCK—Immune System—IL18—atopic dermatitis	1.41e-05	0.000179	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—MAPK8—atopic dermatitis	1.41e-05	0.000179	CbGpPWpGaD
Imatinib—LCK—Hemostasis—IL2—atopic dermatitis	1.4e-05	0.000177	CbGpPWpGaD
Imatinib—LCK—Immune System—CD8A—atopic dermatitis	1.39e-05	0.000176	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NFKBIA—atopic dermatitis	1.39e-05	0.000176	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.38e-05	0.000174	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CD4—atopic dermatitis	1.37e-05	0.000174	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADSL—atopic dermatitis	1.37e-05	0.000173	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CASP8—atopic dermatitis	1.35e-05	0.00017	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NFKBIA—atopic dermatitis	1.35e-05	0.00017	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TAC1—atopic dermatitis	1.34e-05	0.000169	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NPS—atopic dermatitis	1.34e-05	0.000169	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCL5—atopic dermatitis	1.34e-05	0.000169	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.33e-05	0.000167	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CXCL10—atopic dermatitis	1.32e-05	0.000167	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD4—atopic dermatitis	1.32e-05	0.000167	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCR3—atopic dermatitis	1.31e-05	0.000166	CbGpPWpGaD
Imatinib—ABL1—Immune System—NFKBIA—atopic dermatitis	1.31e-05	0.000166	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—IL6—atopic dermatitis	1.3e-05	0.000165	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.27e-05	0.00016	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TNF—atopic dermatitis	1.27e-05	0.00016	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCL5—atopic dermatitis	1.27e-05	0.00016	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL5—atopic dermatitis	1.25e-05	0.000157	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NGF—atopic dermatitis	1.24e-05	0.000156	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.22e-05	0.000154	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CASP8—atopic dermatitis	1.21e-05	0.000153	CbGpPWpGaD
Imatinib—KIT—Immune System—IFNG—atopic dermatitis	1.21e-05	0.000153	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.21e-05	0.000152	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCR5—atopic dermatitis	1.2e-05	0.000152	CbGpPWpGaD
Imatinib—ABL1—Immune System—CASP8—atopic dermatitis	1.18e-05	0.00015	CbGpPWpGaD
Imatinib—LCK—Disease—CCR5—atopic dermatitis	1.18e-05	0.000149	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NGF—atopic dermatitis	1.17e-05	0.000148	CbGpPWpGaD
Imatinib—KIT—Immune System—CD4—atopic dermatitis	1.17e-05	0.000148	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.17e-05	0.000148	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.17e-05	0.000147	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—MAPK8—atopic dermatitis	1.16e-05	0.000147	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IFNG—atopic dermatitis	1.15e-05	0.000145	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCR5—atopic dermatitis	1.14e-05	0.000144	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCL5—atopic dermatitis	1.14e-05	0.000144	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.14e-05	0.000144	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD4—atopic dermatitis	1.11e-05	0.00014	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—IL6—atopic dermatitis	1.09e-05	0.000137	CbGpPWpGaD
Imatinib—LCK—Immune System—NFKBIA—atopic dermatitis	1.08e-05	0.000137	CbGpPWpGaD
Imatinib—KIT—Immune System—IL1B—atopic dermatitis	1.08e-05	0.000137	CbGpPWpGaD
Imatinib—KIT—Disease—CD4—atopic dermatitis	1.08e-05	0.000136	CbGpPWpGaD
Imatinib—KIT—Immune System—IL2—atopic dermatitis	1.08e-05	0.000136	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCL10—atopic dermatitis	1.06e-05	0.000134	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.06e-05	0.000134	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NGF—atopic dermatitis	1.06e-05	0.000133	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.04e-05	0.000131	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IFNG—atopic dermatitis	1.03e-05	0.000131	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—IL6—atopic dermatitis	1.03e-05	0.00013	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCR5—atopic dermatitis	1.03e-05	0.00013	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL1B—atopic dermatitis	1.02e-05	0.000129	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CD4—atopic dermatitis	1.02e-05	0.000129	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—IL6—atopic dermatitis	1.02e-05	0.000129	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NFKBIA—atopic dermatitis	1.02e-05	0.000129	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL2—atopic dermatitis	1.02e-05	0.000129	CbGpPWpGaD
Imatinib—ABL1—Immune System—IFNG—atopic dermatitis	1.01e-05	0.000127	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD4—atopic dermatitis	9.97e-06	0.000126	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CXCL8—atopic dermatitis	9.93e-06	0.000126	CbGpPWpGaD
Imatinib—KIT—Immune System—MAPK8—atopic dermatitis	9.9e-06	0.000125	CbGpPWpGaD
Imatinib—LCK—Immune System—CASP8—atopic dermatitis	9.75e-06	0.000123	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD4—atopic dermatitis	9.72e-06	0.000123	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NFKBIA—atopic dermatitis	9.66e-06	0.000122	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL2—atopic dermatitis	9.49e-06	0.00012	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GLB1—atopic dermatitis	9.39e-06	0.000119	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—MAPK8—atopic dermatitis	9.38e-06	0.000118	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—IL6—atopic dermatitis	9.26e-06	0.000117	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL1B—atopic dermatitis	9.21e-06	0.000116	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CD4—atopic dermatitis	9.21e-06	0.000116	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL2—atopic dermatitis	9.18e-06	0.000116	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PPARA—atopic dermatitis	9.15e-06	0.000116	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL5—atopic dermatitis	9.15e-06	0.000116	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PPARA—atopic dermatitis	9.07e-06	0.000115	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PPARA—atopic dermatitis	9.06e-06	0.000114	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—IL6—atopic dermatitis	9.02e-06	0.000114	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADSL—atopic dermatitis	9.01e-06	0.000114	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL1B—atopic dermatitis	8.98e-06	0.000113	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL2—atopic dermatitis	8.94e-06	0.000113	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.87e-06	0.000112	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PPARA—atopic dermatitis	8.79e-06	0.000111	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MAPK8—atopic dermatitis	8.74e-06	0.00011	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NFKBIA—atopic dermatitis	8.71e-06	0.00011	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NGF—atopic dermatitis	8.47e-06	0.000107	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—MAPK8—atopic dermatitis	8.45e-06	0.000107	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PPARA—atopic dermatitis	8.44e-06	0.000107	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IL2—atopic dermatitis	8.39e-06	0.000106	CbGpPWpGaD
Imatinib—LCK—Immune System—IFNG—atopic dermatitis	8.29e-06	0.000105	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCR5—atopic dermatitis	8.24e-06	0.000104	CbGpPWpGaD
Imatinib—ABL1—Immune System—MAPK8—atopic dermatitis	8.23e-06	0.000104	CbGpPWpGaD
Imatinib—LCK—Immune System—CD4—atopic dermatitis	8e-06	0.000101	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—IL6—atopic dermatitis	7.43e-06	9.39e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL1B—atopic dermatitis	7.39e-06	9.34e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CD4—atopic dermatitis	7.39e-06	9.34e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL2—atopic dermatitis	7.36e-06	9.31e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CXCL8—atopic dermatitis	7.28e-06	9.2e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NFKBIA—atopic dermatitis	6.99e-06	8.83e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL2—atopic dermatitis	6.96e-06	8.79e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CXCL8—atopic dermatitis	6.89e-06	8.71e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—MAPK8—atopic dermatitis	6.78e-06	8.57e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL2—atopic dermatitis	6.59e-06	8.32e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARA—atopic dermatitis	6.56e-06	8.29e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MAPK8—atopic dermatitis	6.4e-06	8.09e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL6—atopic dermatitis	6.32e-06	7.99e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CXCL8—atopic dermatitis	6.21e-06	7.85e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MAPK8—atopic dermatitis	6.06e-06	7.66e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—atopic dermatitis	5.99e-06	7.57e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL2—atopic dermatitis	5.93e-06	7.5e-05	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—atopic dermatitis	5.84e-06	7.38e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARA—atopic dermatitis	5.65e-06	7.14e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—atopic dermatitis	5.58e-06	7.05e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—atopic dermatitis	5.53e-06	6.99e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MAPK8—atopic dermatitis	5.46e-06	6.9e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—atopic dermatitis	5.39e-06	6.82e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—atopic dermatitis	5.26e-06	6.64e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARA—atopic dermatitis	5.07e-06	6.41e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCL8—atopic dermatitis	4.98e-06	6.3e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—atopic dermatitis	4.98e-06	6.29e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARA—atopic dermatitis	4.95e-06	6.25e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL2—atopic dermatitis	4.76e-06	6.02e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARA—atopic dermatitis	4.66e-06	5.89e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARA—atopic dermatitis	4.62e-06	5.84e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MAPK8—atopic dermatitis	4.38e-06	5.54e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—atopic dermatitis	4.33e-06	5.47e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—atopic dermatitis	4.09e-06	5.17e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—atopic dermatitis	4e-06	5.05e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARA—atopic dermatitis	3.95e-06	4.99e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—atopic dermatitis	3.87e-06	4.89e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—atopic dermatitis	3.49e-06	4.41e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARA—atopic dermatitis	3.05e-06	3.85e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—atopic dermatitis	2.8e-06	3.54e-05	CbGpPWpGaD
